<DOC>
	<DOC>NCT01262170</DOC>
	<brief_summary>A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke</brief_summary>
	<brief_title>A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers</brief_title>
	<detailed_description>Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Healthy adult smokers Smoking for at least 5 years Smoking at least one (1) pack of cigarettes a day Allergy to lozenge components</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>dietary supplement</keyword>
	<keyword>nutraceutical</keyword>
</DOC>